Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

TBPHTheravance Biopharma, Inc.

$700M

Q3 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$19M

Gross Profit

$19M98.3% margin

Operating Income

-$33M-175.6% margin

Net Income

-$34M-178.0% margin

EPS (Diluted)

$-0.73

QoQ Revenue Growth

+248.7%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$356M

Total Liabilities

$58M

Stockholders' Equity

$298M

Cash & Equivalents

$87M

← FY 2016 All Quarters Q4 2016 →

TBPH Q3 2016 Earnings — Theravance Biopharma, Inc. Revenue & Financial Results | Market Cap Arena